
Taysha Gene Therapies (TSHA)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy TSHA Stock
Start investing in TSHA
About Taysha Gene Therapies (TSHA)
Market cap | $664.29M |
Today's volume | 2.47M |
Revenue (TTM) | $7.22M |
Avg. daily volume | 3.63M |
EBITDA (TTM) | -$82.52M |
Open | $2.58 |
Price / earnings ratio | -7.12x |
Today's range | $2.49 - $2.64 |
Debt / equity | 112.66x |
52 week range | $1.05 - $4.07 |
5 year debt / equity | 1277.26x |
Beta (LTM) | 1.23x |
Interest coverage | -849.23x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 5.35x |
Ex-dividend date | — |
Next earnings | Aug 11, 2025 |
Dividend payable date | — |
TSHA Stock Rating
TSHA Stock News
View all



Frequently Asked Questions (FAQ)
How to buy TSHA stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in TSHA stock
Navigate to the Explore page. Then, type TSHA into the search bar. When you see TSHA stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased TSHA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Taysha Gene Therapies Stock Earnings
The value each TSHA share was expected to gain vs. the value that each TSHA share actually gained.
TSHA (TSHA) reported Q1 2025 earnings per share (EPS) of -$0.08, beating estimates of -$0.09 by 11.11%. In the same quarter last year, TSHA's earnings per share (EPS) was -$0.10. TSHA is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of $0.